Are there indicators of remyelination in blood or CSF of multiple sclerosis patients?

Multiple Sclerosis

Volumn 4, Issue 3, 1998, Pages 228-231

  Massaro, A R ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Biological markers; Cerebrospinal fluid; CNTF; Multiple sclerosis; N CAM; Remyelination; S 100

Indexed keywords

BIOLOGICAL MARKER; CILIARY NEUROTROPHIC FACTOR; NERVE CELL ADHESION MOLECULE; PROTEIN S 100;

ARTICLE; BLOOD; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID LEVEL; HUMAN; MULTIPLE SCLEROSIS; REMYELINIZATION;

EID: 0031690958     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859800400326     Document Type: Article

References (29)

1. Greenfield JG, King LS. (1958) Demyelinating diseases. In: Greenfield JG et al. (eds). Greenfield's Neuropathology. London: Edward Arnold pp. 441-474.
2. Lumsden CE. (1970) The neuropathology of multiple sclerosis. In: Vinken PJ & Bruyn GW (eds). Handbook of Clinical Neurology, vol. 9. Amsterdam: North-Holland PC pp. 217-309.
3. Prineas JW et al. (1993) Multiple sclerosis: remyelination of nascent lesion. Ann Neurol 33: 137-151.
4. Ozawa K et al. (1994) Patterns of oligodendroglia pathology in multiple sclerosis. Brain 117: 1311-1322.
5. Edelman GM. (1986) Cell adhesion molecules in the regulation of animal form and tissue pattern. Ann Rev Cell Biol 2: 81-116.
6. Cioffi RP, Carbone G, Massaro AR. (1986) Alcuni aspetti neurobiologici della N-CAM. Arch Psicol Neurol Psich 47: 191-208.
7. Bock E, Edvardsen K, Linneman D, Nybroe O. (1988) Structure and function of soluble NCAM. In: Gorio A, Perez-Polo JR, de Vellis J, Haber B (eds). Neural Development and Regeneration. Berlin-Heidelberg: Springer-Verlag pp. 343-352.
8. Bath S, Silberberg DH. (1986) Oligodendrocyte cell adhesion molecules are related to N-CAM. J Neurosci 6: 3348-3354.
9. Bath S, Silberberg DH. (1988) N-CAM 180, the largest component of the N-CAM, is reduced in dysmyelinating quaking mutant mouse brain. Brain Res 452: 373-377.
10. Bath S, Silberberg DH. (1988) Developmental expression of N-CAM of oligodendrocytes in vivo and in culture. J Neurochem 50: 1830-1838.
11. Ono J et al. (1994) Central nervous system abnormalities in chromosome deletion at 11q23. Clin Genet 45: 325-329.
12. Montag D et al. (1994) Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron 13: 229-246.
13. Tacke R & Martini R. (1990) Changes in expression of mRNA specific for cell adhesion molecules (L1 and N-CAM) in the transected peripheral nerve of the adult rat. Neuroscience Letters 120: 227-230.
14. Nait Oumesmar B et al. (1995) Expression of the highly polysialylated neural cell adhesion molecule during postnatal and following chemically induced demyelination of the adult mouse spinal cord. Europ J Neurosci 7: 480-491.
15. Massaro AR, Scivoletto G, Tonali P. (1990) Cerebrospinal fluid markers in neurological disorders. It J Neurol Sci 11: 537-547.
16. Massaro AR, Albrechtsen M, Bock E. (1987) N-CAM in CSF; a marker of synaptic remodelling after acute phases of multiple sclerosis? It J Neurol Sci s6: 85-88.
17. Ibsen S, Berezin V, Nørgaard Pedersen B, Bock E. (1983) Enzyme-linked immunosorbent assay of the D2 glycoprotein. J Neurochem 41: 356-362.
18. Massaro AR, Albrechtsen M, Bock E. (1987) Determination of the neural-cell adhesion molecule (N-CAM) in cerebrospinal fluid from patients with multiple sclerosis. In: Lowenthal A & Raus J (eds). Cellular and Humoral Immunological Components of Cerebrospinal Fluid in Multiple Sclerosis. New York: Plenum PC pp. 397-402.
19. Massaro AR et al. (1985) Myelin basic protein and S-100 antigen in cerebrospinal fluid of patients with multiple sclerosis in the acute phase. It J Neurol Sci 6: 53-56.
20. Massaro AR. La sclerosi multipla. In: Bergonzi P & Massaro AR (eds). Trattato Italiano di Neurologia, vol. 4. Roma: Verduci Editore (in press).
21. Massaro AR, Carnevale A, Tonali P, Bock E. (1997) Glial cell pathobiology in multiple sclerosis detected by CSF markers. In: Teelken AW & Korf J (eds). Neurochemistry. New York: Plenum PC pp. 451-455.
22. Massaro AR & Tonali P. (1998) Cerebrospinal fluid markers in multiple sclerosis: an overview. Multiple Sclerosis 4: 1-4.
23. Massaro AR, Cioffi R, Carbone G. (1988) Serum and cerebrospinal fluid levels of N-CAM in multiple sclerosis patients. Europ J Neurosci s1: 328.
24. Louis J-C, Magal E, Takayama S, Varon S. (1993) CNTF protection of oligodendrocytes against natural and tumor necrosis factor induced death. Science 259: 689-692.
25. D'Souza S, Alinauskas K, Antel JP. (1996) Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury. J Neurosci Res 43: 289-298.
26. Winter CG, Saotome Y, Levison SW, Hirsh D. (1995) A role for ciliary neurotrophic factor as an inducer of reactive gliosis, the glial response to central nervous system injury. Proc Natl Acad Sci USA 92: 5865-5869.
27. Smith GM, Rabinovsky ED, McManaman JL, Shine HD. (1993) Temporal and spatial expression of ciliary neurotrophic factor after peripheral nerve injury. Exp Neurol 121: 239-247.
28. Massaro AR, Soranzo C, Carnevale A. (1997) Cerebrospinal fluid ciliary neurotrophic factor (CNTF) in neurological patients. Europ Neurol 37: 243-246.
29. Massaro AR et al. (1997) Neurotrophic factors in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. In: Abramski O & Ovadia H (eds). Frontiers in Multiple Sclerosis. London: Martin Dunitz Publisher pp. 155-160.